Related Articles
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
Single‑dose intra‑arterial neoadjuvant chemotherapy while waiting for radical hysterectomy for stage IB‑IIB cervical cancer
CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer
Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma